Research letters - page 3

Evaluation of the prevalence of hepatitis C virus infection in patients with hemophilia treated in a single hemophilia center in Poland

Anna Schneider, Ewelina Wojtasińska, Katarzyna Pielaszkiewicz, Monika Joks, Lidia Gil, Joanna Rupa-Matysek

Pol Arch Intern Med. 2023, Vol. 133, No. 5: 16438 / DOI: 10.20452/pamw.16438

Second allogeneic hematopoietic stem cell transplantation for relapsed acute myeloid leukemia: a retrospective single-center analysis of the outcome

Anna Łojko, Joanna Rupa-Matysek, Magdalena Matuszak, Dominik Dytfeld, Lidia Gil

Pol Arch Intern Med. 2023, Vol. 133, No. 3: 16437 / DOI: 10.20452/pamw.16437

Ruxolitinib is highly effective in steroid-resistant graft-versus-host disease: real-world data from a single center

Adrianna Spałek, Agata Wieczorkiewicz-Kabut, Patrycja Zielińska, Anna Kopińska, Grzegorz Helbig

Pol Arch Intern Med. 2023, Vol. 133, No. 3: 16435 / DOI: 10.20452/pamw.16435

Assessment of neurocognitive functions in patients with vasovagal syndrome

Joanna Jędrzejczyk-Spaho, Artur Pietrucha, Wojciech Zasada, Ewa Konduracka, Jadwiga Nessler

Pol Arch Intern Med. 2023, Vol. 133, No. 2: 16426 / DOI: 10.20452/pamw.16426

The role of red blood cells in hemostasis and whole blood clot contraction in adults after the Fontan procedure

Paweł Skorek, Maciej Skubera, Joanna Natorska, Michał Ząbczyk, Monika Smaś-Suska, Lidia Tomkiewicz-Pająk

Pol Arch Intern Med. 2023, Vol. 133, No. 2: 16412 / DOI: 10.20452/pamw.16412

Invasive assessment of the microvascular coronary circulation in patients with coronary artery aneurysmal disease

Sylwia Iwańczyk, Anna Smukowska-Gorynia, Patrycja Woźniak, Marek Grygier, Maciej Lesiak, Aleksander Araszkiewicz

Pol Arch Intern Med. 2023, Vol. 133, No. 1: 16392 / DOI: 10.20452/pamw.16392

Safety of COVID-19 vaccines and factors influencing the vaccine take-up rate in Polish adults with epilepsy: a single-center study

Aleksandra Pawlicka, Kamil Wężyk, Katarzyna Matwiej, Radosław Dziedzic, Agnieszka Słowik, Magdalena Bosak

Pol Arch Intern Med. 2023, Vol. 133, No. 1: 16389 / DOI: 10.20452/pamw.16389

Dapagliflozin reduces plasma concentration of plasminogen activator inhibitor-1 in patients with heart failure with preserved ejection fraction and type 2 diabetes

Artur Dziewierz, Michał Zabojszcz, Joanna Natorska, Magdalena Ślusarczyk-Dolecka, Martyna Kuleta, Zbigniew Siudak

Pol Arch Intern Med. 2022, Vol. 132, No. 12: 16383 / DOI: 10.20452/pamw.16383

Hemoglobin level as a predictor of major adverse cardiac events during a long-term follow-up in patients with coronary artery disease

Anna Oleksiak, Cezary Kępka, Karolina Rucińska, Kamil Marcinkiewicz, Marcin Demkow, Mariusz Kruk

Pol Arch Intern Med. 2022, Vol. 132, No. 12: 16377 / DOI: 10.20452/pamw.16377

Oxidized phospholipids associated with lipoprotein(a) contribute to hypofibrinolysis in severe aortic stenosis

Magdalena Kopytek, Michał Ząbczyk, Piotr Mazur, Jakub Siudut, Joanna Natorska

Pol Arch Intern Med. 2022, Vol. 132, No. 11: 16372 / DOI: 10.20452/pamw.16372

Denser fibrin clot networks in patients at high risk of recurrent arterial thromboembolism following acute limb ischemia of unknown cause

Tomasz Nowakowski, Krzysztof Batko, Anetta Undas

Pol Arch Intern Med. 2022, Vol. 132, No. 11: 16358 / DOI: 10.20452/pamw.16358

Relationship between COVID-19 severity, markers of endothelial impairment, and Simple Covid Risk Index

Mateusz Fabiś, Paulina Gorzelak-Pabiś, Joanna Satała, Agnieszka Pawlos, Jarosław Fabiś, Marlena Broncel

Pol Arch Intern Med. 2022, Vol. 132, No. 10: 16348 / DOI: 10.20452/pamw.16348

Safety and feasibility of single-day coronary angioplasty in low- and moderate-risk patients: candidate selection criteria, management protocol, and outcomes

Andrzej Ciszewski

Pol Arch Intern Med. 2022, Vol. 132, No. 10: 16330 / DOI: 10.20452/pamw.16330

Unfavorably altered fibrin clot properties are associated with recurrent venous thromboembolism in patients following post‑discharge events

Kamila W. Undas, Jakub Siudut, Michał Ząbczyk

Pol Arch Intern Med. 2022, Vol. 132, No. 9: 16326 / DOI: 10.20452/pamw.16326

Revascularization in patients with ST‑segment elevation myocardial infarction and multivessel coronary artery disease: preliminary results from a large multicenter national registry

Marcin Sadowski, Krzysztof Milewski, Łukasz Zandecki, Michał Skrzypek, Mariusz Gąsior, Wojciech Wojakowski

Pol Arch Intern Med. 2022, Vol. 132, No. 9: 16315 / DOI: 10.20452/pamw.16315

A series of Polish patients with congenital fibrinogen disorders: 2 new mutations in fibrinogen gamma chain, Fibrinogen Kostrzyn and Fibrinogen Łódź II

Anna Weronska, Anna Klukowska, Marguerite Neerman-Arbez, Jacek Treliński, Anetta Undas, Ewa Wypasek

Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16314 / DOI: 10.20452/pamw.16314

Treatment of acute coronary syndromes during the COVID‑19 pandemic: a designated COVID‑19 hospital perspective

Marek Słomczyński, Janusz Rzeźniczak, Dominika Kasprzak, Paweł Bugajski, Andrzej Bolewski, Paweł Burchardt

Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16298 / DOI: 10.20452/pamw.16298

Increased endocan expression as a biomarker of endothelial dysfunction in patients with metabolic syndrome

Sylwia Iwańczyk, Anna Smukowska-Gorynia, Patrycja Woźniak, Marek Grygier, Maciej Lesiak, Aleksander Araszkiewicz

Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16292 / DOI: 10.20452/pamw.16292

Changes of lipid profile in subclinical hyperthyroidism and following restoration of euthyroidism

Grzegorz Kamiński, Michał Olejarz, Ewelina Szczepanek-Parulska, Marek Ruchała, Marek Saracyn

Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16277 / DOI: 10.20452/pamw.16277

Altered fecal short‑chain fatty acid profile as a potential marker of disease activity in patients with ulcerative colitis and Crohn’s disease: a pilot study

Olga Kaczmarczyk, Agnieszka Dąbek-Drobny, Michał Woźniakiewicz, Paweł Paśko, Agnieszka Piątek-Guziewicz, Małgorzata Zwolińska-Wcisło

Pol Arch Intern Med. 2022, Vol. 132, No. 6: 16254 / DOI: 10.20452/pamw.16254

previousof 12next

Impact Factor 2022

4.8

IC value for 2022

217.18

Ministry of Education and Science score

200
Average times from:
submission to 1st decision, 2 days
submission to first reviews, 24 days
acceptance to online first publication, 5 days
acceptance to final publication, 45 days

Current manuscript acceptance rate: 27%
The journal is co-financed from the state budget under the "Development of scientific journals" program of the Ministry of Education and Science in the years 2022-2024. Read more